Compound inhibitors of phosphatidylinositol 3 Kinase (pi-3)； uses prolifertivas against diseases.

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

HIRAWAT SAMIT,MASSACESI CRISTIAN

申请号：

CL2014003101

公开号：

CL2014003101A1

申请日:

2014.11.14

申请国别(地区):

CL

年份:

2015

代理人:

摘要：

The present invention relates to a dosage regimen for a phosphatidylinositol 3-kinase (PI3K) inhibitor compound of formula (I) or a pharmaceutically acceptable salt thereof. More specifically, the present invention relates to a dosage regimen for the treatment of patients suffering from a proliferative disease, such as, for example, cancer, with a phosphatidylinositol 3-kinase (PI3K) inhibitor compound of formula (I) or a pharmaceutically acceptable salt thereof.USO DE COMPUESTOS DERIVADOS DE 2-MORFOLINOPIRIMIDINA, INHIBIDORES DE FOSFATIDILINOSITOL-3-QUINASA (PI3K) PARA EL TRATAMIENTO DE ENFERMEDADES PROLIFERATIVAS.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/